Tango Therapeutics, Inc.

Direct answer

Tango Therapeutics, Inc. is publicly traded on NASDAQ under the ticker TNGX.

Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5). This compound is currently being advanced as a potential therapy for cancers characterized by methylthioadenosine phosphorylase (MTAP) deletions....

Can you invest in Tango Therapeutics, Inc.?

Yes. Tango Therapeutics, Inc. is publicly traded on NASDAQ under the ticker TNGX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Tango Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.